Source: Cancers. Unidade: FMRP
Subjects: MEDULOBLASTOMA, GENÔMICA, NEOPLASIAS, BIOMARCADORES, TERAPIA COMBINADA
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, v. 13, n. 24, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13246249. Acesso em: 26 ago. 2024.APA
Cruzeiro, G. A. V., Magalhães, T. de A., Sousa, G. R. de, Silva, R. B., Biagi Junior, C. A. O. de, Chagas, P. F. das, et al. (2021). YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, 13( 24), 1-11. doi:10.3390/cancers13246249NLM
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 ago. 26 ] Available from: https://doi.org/10.3390/cancers13246249Vancouver
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 ago. 26 ] Available from: https://doi.org/10.3390/cancers13246249